|Aug 18, 2017|
|Aug 18, 2017|
Currency in IDR
|Full time employees:||12,736|
PT Kalbe Farma Tbk engages in the development, production, distribution, and trade of pharmaceutical products. It operates through the following segments: Prescription Pharmaceutical, Consumer Health, Nutritionals, and Distribution and Logistic. The Prescription Pharmaceutical segment offers generic drugs, branded generics, and licensed drugs, which are distributed to hospitals, pharmacies, and drug stores throughout Indonesia. The Consumer Health segment provides over-the-counter drugs, consumer products, food supplements, preventive products, energy drinks, and healthy ready-to-drink products. The Nutritionals segment sells biscuits, cereals, and milk products for infants, toddlers, children, pre-teenagers, adults, expectant and lactating mothers, and elderly; as well as nutritional products for consumers with special medical needs. The Distribution and Logistics segment maintains distribution of the company's and third party principal's products across Indonesia, and focuses on the trading of raw material, medical devices, and retail health service. The company founded by Boenyamin Setiawan on September 10, 1966 and is headquartered in Jakarta, Indonesia.
Indonesia's Kalbe Farma is one of Southeast Asia's largest pharmaceutical companies. It has a diverse lineup of products, ranging from prescription medicine to vitamins to energy drinks.
The company has its own distribution network that carries products to a large number of retail outlets. It also distributes products for major foreign pharmaceutical companies, including Astellas Pharma of Japan and Baxter of the U.S.
Kalbe Farma was launched out of a garage by Boenjamin Setiawan, who is now in his 80s, and his brothers. Setiawan has left the board of directors and now serves as honorary chairman. His niece, Bernadette Ruth Irawati Setiady, has served as president since 2008. The group of founders holds a significant stake in the company.
Kalbe Farma has been expanding its consumer sector, acquiring local health-drink producer Hale International in 2012. The company exports some of its products to neighboring countries.
In the news
June 15, 2017 10:00 am JST
October 27, 2016 12:00 pm JST
Company in focus
October 23, 2016 3:00 pm JST
September 29, 2016 3:45 pm JST
September 29, 2016 12:00 pm JST
June 16, 2016 12:00 pm JST
- Local currency
- US Dollar
|Income before tax||3,091.18B|
|Dividends per share||22|
|Operating cash flow||2,233.38B|
Currency in IDR
|Income before tax||232.41M|
|Dividends per share||0.00|
|Operating cash flow||167.91M|
Currency in USD
- President Director: Bernadette Ruth Setiady
- Head-Corporate Finance, Accounting & Tax: Bernadus Karmin Winata
- Head-Corporate Information Technology & System: Dino Bramanto
- Director: Bujung Nugroho
- Director: Ongkie Tedjasurja
- PT Gira Sole Prima(10.1%)
- PT Santa Seha Sanadi(9.6%)
- PT Diptanala Bahana(9.4%)
- PT Lucasta Murni Cemerlang(9.4%)
- PT Ladang Ira Panen(9.2%)
- PT Bina Arta Charisma(8.5%)
- First State Investment Management (UK) Ltd.(1.6%)
- PT Schroder Investment Management Indonesia(1.4%)
- The Vanguard Group, Inc.(1.3%)
- BlackRock Fund Advisors(1.2%)
- Website: http://www.kalbe.co.id
- Address: Gedung KALBE, Jalan Let. Jend. Suprapto Kavling 4, Jakarta, 10510, Indonesia
- Phone: +62.21.4287.3888
Copyright © 2017 FactSet Research Systems Inc. All rights reserved.